Warren Buffett Gives Nod to TSX Stocks

Warren Buffett and Charlie Munger held court this past weekend at the Berkshire Hathaway Inc. (NYSE:BRK.A)(NYSE:BRK.B) annual meeting. If you read between the lines, he was endorsing TSX stocks. Here’s why.

| More on:
The Motley Fool

Investors of all stripes invaded Omaha, Nebraska, this past weekend for the Berkshire Hathaway Inc. (NYSE:BRK.A)(NYSE:BRK.B) annual meeting. Among the topics covered by Warren Buffett and Charlie Munger in their usual kitschy style was the American healthcare system and the Republican’s plan to repeal and replace Obamacare.

From all the meeting transcripts I’ve read, it’s evident the boys from Berkshire Hathaway give socialized medicine a ringing endorsement.

“Medical costs are the tapeworm of American economic competitiveness,” Buffett said May 6. “That is a problem this society is having trouble with and is going to have more trouble with.”

That’s not good news if you’re an American or an American business. Munger went further: “A benign despot would create a single payer system with people being able to opt out into private care that was a little faster or a little fancier like all of Europe and Canada,” he said in an interview prior to the meeting with Yahoo Finance’s Andy Server. “I think you young people will live to see a healthcare system that looks a lot like Canada’s with a better private opt out system. I won’t (Munger is 93).”

That’s good news if you’re a Canadian or a Canadian company.

Forget the middle class

Buffett didn’t directly come out and say it, but he might as well have, because his comments, along with those of his vice chairman, made it obvious they were not fans of the Republican’s designs on healthcare.

He’s especially outraged by the fact that his taxes would go down under the American Health Care Act (AHCA), suggesting the AHCA will lower taxes for anyone earning more than $250,000.

“The net effect of that act is that my federal income taxes would have gone down, down 17%, last year,” Buffett said at the annual meeting. “It’s a huge tax cut for guys like me. That means one of two things: either the deficit goes up, or someone else’s taxes do.”

So, no matter what you think of Prime Minister Trudeau, his plan for the country seems far more helpful to the middle class than whatever it is that Trump is selling to Americans.

Buy Canada, buy TSX

I have always wondered why more American businesses don’t expand into Canada for precisely the reasons Buffett and Munger mentioned at Berkshire Hathaway’s annual meetings.

In 2015, U.S. healthcare spending was US$9,990 ($12,500 Canadian) per person, accounting for 17.8% of America’s GDP. In 2016, Canada spent $6,299 per person, or 11% of our GDP.

So, if you open a factory in Canada with 1,000 jobs, the healthcare cost is absorbed by your employees and the various levels of government and costs the system $6.3 million annually to provide those workers with healthcare. In the U.S., the company and staff take up much of the expense, and it costs the system $12.5 million annually, or twice as much.

Now, I get that this is an oversimplification of the issue. Virtually every other expense a Canadian company must absorb is generally higher north of the border — real estate and leasing costs as well as wages being the biggest — but it definitely points out a huge advantage in doing business in Canada as opposed to the U.S.

Companies such as Alimentation Couch Tard Inc. (TSX:ATD.B) and Restaurant Brands International Inc. (TSX:QSR)(NYSE:QSR) understand this, and that’s why they’re headquartered here as opposed to in the U.S.

Sure, QSR’s reasons have more to do with lower corporate taxes, but healthcare is still a reason for it to remain north of the border, even after the U.S. lowers its corporate income taxes.

Bottom line

You might not realize it when you plunk down your money to buy Couche Card or QSR stock, but our healthcare system is a big reason the two old guys from Berkshire Hathaway think a single-payer system is the way to go.

Take advantage of this built-in edge over our American counterparts and buy TSX companies. For once, home-country bias makes sense.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Will Ashworth has no position in any stocks mentioned. The Motley Fool owns shares of Berkshire Hathaway (B shares) and RESTAURANT BRANDS INTERNATIONAL INC. Alimentation Couche Tard is a recommendation of Stock Advisor Canada.

More on Investing

financial freedom sign
Dividend Stocks

The Dividend Dream: 23% Returns to Fuel Your Income Dreams

If you want growth and dividend income, consider this dividend stock that continues to rise higher after October lows.

Read more »

You Should Know This
Top TSX Stocks

3 Things About Couche-Tard Stock Every Smart Investor Knows

Alimentation Couche-Tard (TSX:ATD) stock may sustain a growth trajectory in two ways. However, smart investors appreciate one growing risk.

Read more »

IMAGE OF A NOTEBOOK WITH TFSA WRITTEN ON IT
Tech Stocks

The Ultimate Growth Stocks to Buy With $7,000 Right Now

These two top Canadian stocks have massive growth potential, making them two of the best to buy for your TFSA…

Read more »

edit U-turn
Bank Stocks

TD Stock: Why I Reversed Course

Toronto-Dominion Bank (TSX:TD) is one stock I reversed course on in a big way.

Read more »

railroad
Dividend Stocks

Here’s Why CNR Stock Is a No-Brainer Value Stock

Investors in Canadian National Railway (TSX:CNR) stock have had a great year, and here's why that trajectory can continue.

Read more »

A shopper makes purchases from an online store.
Tech Stocks

Down 21%, Is Shopify Stock a Buy on the TSX Today?

Shopify (TSX:SHOP) stock certainly rose in 2023 but is now down 21% from 52-week highs. So, is it a buy…

Read more »

healthcare pharma
Investing

Down 15% Since Earnings: Is WELL Health a Good Stock to Buy?

Despite the near-term weakness, WELL Health offers excellent buying opportunities for long-term investors, given the expanding addressable markets and attractive…

Read more »

clock time
Investing

Is It Too Late to Buy Costco Stock Now?

Costco stock has rallied almost 2,000% in the last 20 years, but the ride is not over yet as international…

Read more »